Name: Immunotherpy in Head and Neck Cancer (en Inglés)
Price: 2184.31 MXN
Availability: InStock
Author: Saini, Deepika ; Gupta, Ds ; Jain, Aashita
ISBN: 9786207474936

Envío gratis

portada Immunotherpy in Head and Neck Cancer (en Inglés)

Formato

Libro Físico

Autor

Deepika Saini

Ds Gupta

Aashita Jain

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

164

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.0 cm

Peso

0.25 kg.

ISBN13

9786207474936

Categorías

Odontología

Immunotherpy in Head and Neck Cancer (en Inglés)

Deepika Saini (Autor) · Ds Gupta (Autor) · Aashita Jain (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo

$ 2,184.31

$ 3,640.52

Ahorras: $ 1,456.21

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 15 de Julio y el Martes 23 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Immunotherpy in Head and Neck Cancer (en Inglés)"

Immunotherapy has revolutionized the treatment landscape for head and neck cancer, offering new hope and improved outcomes for patients. This approach harnesses the power of the immune system to target and destroy cancer cells, providing a more targeted and potentially less toxic alternative to traditional treatments like chemotherapy and radiation therapy. Key immunotherapy strategies in head and neck cancer include immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, and combination therapies. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, block the inhibitory signals that cancer cells use to evade detection by the immune system, allowing immune cells to recognize and attack the tumor.Adoptive cell therapies, like CAR-T cell therapy, involve engineering a patient's own immune cells to specifically target cancer cells. Cancer vaccines aim to stimulate the immune system to recognize and attack cancer cells, either by using tumor antigens or dendritic cells to boost immune responses. Overall, immunotherapy represents a promising approach for head and neck cancer, offering personalized and targeted treatments that can improve survival rates.